Sunday, September 20, 2020
Home International Russia makes an agreement for Sputnik V trials, distribution in India

Russia makes an agreement for Sputnik V trials, distribution in India

Russian sovereign wealth fund has made an agreement with Indian pharma company Dr. Reddy Laboratories for clinical trials and distribution of Sputnik V in India. The Indian regulatory body – Drugs Controller General of India (DCGI) has not permitted the experiment trials in the country yet. Last month, the Russian government had already approved the Sputnik V as the first COVID-19 vaccine in the world but it is yet to start the large scale clinical trials. The Russian Direct Investment Fund (RDIF) has already made an agreement to supply 100 million doses of the vaccine with Dr. Reddy Labs in India.

Read More – Hindustan Times | DNA India | India News | NDTV


You will be redirected to your submitted article automatically. Please do not leave the page after hitting Submit Post.

- Advertisment -

Most Popular

Sennheiser launches CX 400BT earbuds in India: Check price, specs

It has a 7mm dynamic driver unit and a built-in equalizer.

Anand Mahindra to provide tractor to a farmer who carved a 3-km long canal

Farmer Laungi Bhuyian had carved a 3-Km long canal in 30 years to irrigate his farmland.

Apple’s rumored iPhone 12 Pro Max spotted on Antutu benchmark

Apple iPhone 12 Pro Max will be powered by Apple’s A14 Bionic processor.

Samsung Galaxy S20 FE 5G key specs, live images leaked

The much anticipated Galaxy S20 Fan Edition will be launched this year.

Volkswagen teases ‘Taos sub-compact SUV’: Check specs

Volkswagen Taos will likely be powered by a 2.0-liter turbocharged four-cylinder engine.

Motorola to launch Moto E7 Plus in India on this day: Check specs

Moto E7 Plus will be powered by Qualcomm’s Snapdragon 460 processor.